| Literature DB >> 26808578 |
Ziyu Fang1, Chen Xu2, Yaoming Li1, Xiaobing Cai3, Shancheng Ren1, Houqi Liu4, Yue Wang4, Fubo Wang1, Rui Chen1, Min Qu1, Yang Wang5, Yasheng Zhu1, Wei Zhang1, Xiaolei Shi1, Jingjing Yao1, Xu Gao1, Jianguo Hou1, Chuanliang Xu1, Yinghao Sun6.
Abstract
We previously reported that PlncRNA-1, a long non-coding RNA that is up-regulated in prostate cancer (PCa), affects the proliferation and apoptosis of PCa cells. However, the molecular mechanisms underlying these effects remain largely unknown. In this study, we demonstrated that long non-coding RNA PlncRNA-1, whose expression is promoted by Androgen Receptor (AR), protects AR from microRNA-mediated suppression in PCa cells. PlncRNA-1 knockdown resulted in the up-regulation of a series of AR-targeting microRNAs, among which miR-34c and miR-297 were found to regulate both AR and PlncRNA-1 expression at the post-transcriptional level. Functional analysis revealed that miR-34c and miR-297 overexpression down-regulated AR expression and inhibited the expression of downstream AR targets and that PlncRNA-1 overexpression rescued these effects. The association of PlncRNA-1 with tumor progression was also evaluated in mouse xenograft models, PCa tissues (16 paired samples), and blood samples (35 biopsy-negative and 37 biopsy-positive). Together, the data generated in this study indicate that PlncRNA-1 sponges AR-targeting microRNAs to protect AR from microRNA-mediated down-regulation and that these events form a regulatory feed-forward loop in the development of PCa. These findings suggest that PlncRNA-1 might potentially serve as a novel biomarker in PCa and that PlncRNA-1 might warrant further investigation to determine its potential role as a promising therapeutic target in PCa.Entities:
Keywords: Androgen receptor; Long non-coding RNA; PlncRNA-1; Prostate cancer; microRNA
Mesh:
Substances:
Year: 2016 PMID: 26808578 DOI: 10.1016/j.canlet.2016.01.033
Source DB: PubMed Journal: Cancer Lett ISSN: 0304-3835 Impact factor: 8.679